article Deadly bite: How Venomab’s novel research is tackling the global antivenom shortage We caught up with Andreas Laustsen Co-Founder and CEO of… 21 March 2017 | By Niamh Marriott (Drug Target Review) We caught up with Andreas Laustsen Co-Founder and CEO of Venomab, to find the latest in antivenom research…